Raverine 135 indications
Raverine 135 is indicated for the symptomatic treatment
of irritable bowel syndrome and other conditions
usually included in this grouping, such as:
chronic irritable colon, mucous colitis, spastic colitis
and spastic constipation.
Uses of Raverine 135 in details
Raverine 135 is used to treat irritable bowel syndrome (disorder of the intestines that leads to cramps in the abdomen, gas, bloating and changes in bowel habits). It is also used to treat other conditions that involve spasm and pain related to small and large bowel.
Raverine 135 description
Each Raverine 135 tablet also contains the following excipients: Tablet Core: Lactose monohydrate, starch (potato), povidone, talc, magnesium stearate. Tablet Coating: Talc, sucrose, gelatine, acacia, canuba wax.
Each Raverine 135 Retard prolonged-release capsule also contains the following excipients: Magnesium stearate, copolymer of ethyl acrylate and methyl methacrylate, talc, methylhydroxypropylcellulose, methacrylic acid-ethyl acrylate copolymer (1:1) and glycerol.
Raverine 135 dosage
Adult: Raverine 135: 1 tablet thrice daily, taken approximately 20 min before meals.
The physician will advice the patient on the duration of use of Raverine 135. Duration of use is not limited, however, after a period of several weeks when the desired effect has been obtained, the dosage may be gradually reduced.
Missed Dose: If ≥1 dose is missed, continue with the next dose as prescribed. Do not take the missed dose(s) in addition to the regular dose.
Raverine 135 Retard: 1 capsule twice daily, to be given in the morning and evening.
Administration: The tablet/capsule should be swallowed with at least 100 mL (Raverine 135) water and should not be chewed because of the unpleasant taste.
Raverine 135 interactions
Raverine 135: Tell the physician or pharmacist if taking or have recently taken any other medicines including medicines obtained without a prescription.
Interaction studies have only been performed with alcohol. In vitro and in vivo studies in animals have shown no significant interaction between Raverine 135 and ethanol. No other interaction studies have been performed.
Incompatibilities: Not applicable.
Raverine 135 side effects
In therapeutic doses, no adverse effects have
been reported. Rarely allergic reactions (including
rash, urticaria, angioedema), could be noticed.
USE DURING PREGNANCY AND LACTATION:
Animal experiments have failed to show any teratogenic
effects. However, administration of Raverine 135
is to be discouraged during pregnancy.
Raverine 135 is not excreted in the milk of lactating
women after therapeutic doses.
For both cases, the medicine should be used with
Raverine 135 contraindications
No contraindications have been reported.
Raverine 135 does not provoke any atropinic effect and for this reason is not contraindicated in patients with glaucoma or prostatic hypertrophy.
Active ingredient matches for Raverine 135:
List of Raverine 135 substitutes (brand and generic names)
|Sort by popularity|
|Unit description / dosage (Manufacturer)||Price, USD|
|Colofac/Colofac Retard (Thailand)|
|Colofac Retard PR cap 200 mg 30's (Abbott)|
|Colofac tab 135 mg 50's (Abbott)|
|Duspatalin 杜適林 (Hongkong)|
|Mebeverine HCl (Singapore)|
|Mevrin 135 (Myanmar)|
|Mevrin 135 tab 40's (S.J. & G. Fazul Ellahie)|
|Vermeb 135 mg x 5 Blister x 10 Tablet|
- PubChem. "mebeverine". https://pubchem.ncbi.nlm.nih.gov/com... (accessed September 17, 2018).
- DrugBank. "Mebeverine". http://www.drugbank.ca/drugs/DB12554 (accessed September 17, 2018).
- MeSH. "Parasympatholytics". https://www.ncbi.nlm.nih.gov/mesh/68... (accessed September 17, 2018).
ReviewsThe results of a survey conducted on ndrugs.com for Raverine 135 are given in detail below. The results of the survey conducted are based on the impressions and views of the website users and consumers taking Raverine 135. We implore you to kindly base your medical condition or therapeutic choices on the result or test conducted by a physician or licensed medical practitioners.
1 consumer reported usefulWas the Raverine 135 drug useful in terms of decreasing the symptom or the disease?
According to the reports released by ndrugs.com website users, the below mentioned percentages of users say the drug is useful / not useful to them in decreasing their symptoms/disease. The usefulness of the drug depends on many factors, like severity of the disease, perception of symptom, or disease by the patient, brand name used [matters only to a certain extent], other associated conditions of the patient. If the drug is not effective or useful in your case, you need to meet the doctor to get re-evaluated about your symptoms/disease, and he will prescribe an alternative drug.
Consumer reported price estimatesNo survey data has been collected yet
Consumer reported time for resultsNo survey data has been collected yet
Consumer reported ageNo survey data has been collected yet
There are no reviews yet. Be the first to write one!
Information checked by Dr. Sachin Kumar, MD Pharmacology